C26 Sphingomyelin-d4 (d18:1/26:0

Confirm delete?

C26 Sphingomyelin-d₄ (d18:1/26:0-d₄)

Zoom

Cat No: 9003460

Biochemicals - Isotopically Labeled Standards

C26 Sphingomyelin-d4 is intended for use as an internal standard for the quantification of C26 sphingomyelin (Item No. 9003457) by GC- or LC-MS. C26 Sphingomyelin is a sphingolipid that has been found in serum and cell or brain extracts.{40663,54110,5...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

(2S,3R,E)-2-(hexacosanamido-12,12,13,13-d4)-3-hydroxyoctadec-4-en-1-yl (2-(trimethylammonio)ethyl) phosphate

Correlated keywords:

GCMS LCMS deuterium deuterated C 26 hemo phago cytic lympho histio cytosis mono layers

Product Overview:
C26 Sphingomyelin-d4 is intended for use as an internal standard for the quantification of C26 sphingomyelin (Item No. 9003457) by GC- or LC-MS. C26 Sphingomyelin is a sphingolipid that has been found in serum and cell or brain extracts.{40663,54110,54111} C26 Sphingomyelin levels are increased in the serum of patients with hemophagocytic lymphohistiocytosis, an inflammatory condition characterized by excessive immune activation.{54111} C26 Sphingomyelin has been used a component of monolayers to study the influence of sphingomyelin acyl chain length on sphingomyelin-sterol interactions.{54112} [Matreya, LLC. Catalog No. 2213]

Size	500 µg
Shipping	dry ice
Molecular Formula	C₄₉H₉₅D₄N₂O₆P
SMILES	O=C(CCCCCCCCCCC([2H])([2H])C([2H])([2H])CCCCCCCCCCCCC)N[C@@H](COP(OCC[N+](C)(C)C)([O-])=O)[C@H](O)/C=C/CCCCCCCCCCCCC
Molecular Weight	847,3
Formulation	A crystalline solid
Purity	≥99% deuterated forms (d1-d4)
Custom Code	3822.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

C26 Sphingomyelin-d4 (d18:1/26:0-d4)